Megan Garvey

724 total citations
19 papers, 533 citations indexed

About

Megan Garvey is a scholar working on Molecular Biology, Physiology and Biotechnology. According to data from OpenAlex, Megan Garvey has authored 19 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Biotechnology. Recurrent topics in Megan Garvey's work include Alzheimer's disease research and treatments (6 papers), Protein Structure and Dynamics (5 papers) and Computational Drug Discovery Methods (3 papers). Megan Garvey is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Protein Structure and Dynamics (5 papers) and Computational Drug Discovery Methods (3 papers). Megan Garvey collaborates with scholars based in Australia, Germany and New Zealand. Megan Garvey's co-authors include Ulrich Commandeur, Rainer Fischer, Holger Klose, Camilla Lambertz, Isabel Morgado, John A. Carver, Juliet A. Gerrard, Sally L. Gras, Marcus Fändrich and Sarah Meehan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Megan Garvey

19 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan Garvey Australia 12 376 188 147 120 60 19 533
C.C.C. Tonoli Brazil 17 421 1.1× 232 1.2× 31 0.2× 253 2.1× 19 0.3× 21 725
Dina R. Ivanen Russia 14 302 0.8× 146 0.8× 47 0.3× 271 2.3× 7 0.1× 19 528
Yunfeng Ding United States 11 549 1.5× 140 0.7× 120 0.8× 17 0.1× 14 0.2× 21 810
Orly Tabachnikov Israel 8 310 0.8× 104 0.6× 104 0.7× 148 1.2× 94 1.6× 11 502
Hiroko Tsutsumi Japan 13 425 1.1× 126 0.7× 45 0.3× 45 0.4× 6 0.1× 28 563
Sofie Stalmans Belgium 14 475 1.3× 46 0.2× 52 0.4× 16 0.1× 61 1.0× 22 664
Bert Gevaert Belgium 14 421 1.1× 48 0.3× 46 0.3× 12 0.1× 52 0.9× 24 625
Markus Matuschek Germany 11 272 0.7× 133 0.7× 26 0.2× 165 1.4× 18 0.3× 13 479
R.K. Wierenga Finland 10 585 1.6× 50 0.3× 156 1.1× 164 1.4× 21 0.3× 14 737
Franck Fudalej France 11 689 1.8× 260 1.4× 31 0.2× 51 0.4× 16 0.3× 15 753

Countries citing papers authored by Megan Garvey

Since Specialization
Citations

This map shows the geographic impact of Megan Garvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Garvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Garvey more than expected).

Fields of papers citing papers by Megan Garvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Garvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Garvey. The network helps show where Megan Garvey may publish in the future.

Co-authorship network of co-authors of Megan Garvey

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Garvey. A scholar is included among the top collaborators of Megan Garvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Garvey. Megan Garvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Khoo, Keith K., Megan Garvey, Lynne J. Waddington, et al.. (2017). The thermodynamics of Pr55Gag-RNA interaction regulate the assembly of HIV. PLoS Pathogens. 13(2). e1006221–e1006221. 37 indexed citations
2.
3.
Garvey, Megan, Melanie Wulff, Senthil T. Kumar, et al.. (2016). Molecular architecture of Aβ fibrils grown in cerebrospinal fluid solution and in a cell culture model of Aβ plaque formation. Amyloid. 23(2). 76–85. 1 indexed citations
4.
Pham, Son, Thibault Tabarin, Megan Garvey, et al.. (2015). Cryo-electron microscopy and single molecule fluorescent microscopy detect CD4 receptor induced HIV size expansion prior to cell entry. Virology. 486. 121–133. 13 indexed citations
5.
Morgado, Isabel & Megan Garvey. (2015). Lipids in Amyloid-β Processing, Aggregation, and Toxicity. Advances in experimental medicine and biology. 855. 67–94. 56 indexed citations
6.
Lambertz, Camilla, et al.. (2014). Challenges and advances in the heterologous expression of cellulolytic enzymes: a review. Biotechnology for Biofuels. 7(1). 135–135. 136 indexed citations
7.
Garvey, Megan, et al.. (2014). Expression of Recombinant Cellulase Cel5A from <em>Trichoderma reesei</em> in Tobacco Plants. Journal of Visualized Experiments. 5 indexed citations
8.
Esposito, Gennaro, Megan Garvey, Alessandra Corazza, et al.. (2013). Monitoring the Interaction between beta(2)-Microglobulin and the Molecular Chaperone alpha B-crystallin by NMR and Mass Spectrometry alpha B-CRYSTALLIN DISSOCIATES beta(2)-MICROGLOBULIN OLIGOMERS. UCL Discovery (University College London). 2 indexed citations
9.
Ecroyd, Heath, Megan Garvey, David C. Thorn, Juliet A. Gerrard, & John A. Carver. (2013). Amyloid Fibrils from Readily Available Sources: Milk Casein and Lens Crystallin Proteins. Methods in molecular biology. 996. 103–117. 4 indexed citations
10.
Garvey, Megan, Holger Klose, Rainer Fischer, Camilla Lambertz, & Ulrich Commandeur. (2013). Cellulases for biomass degradation: comparing recombinant cellulase expression platforms. Trends in biotechnology. 31(10). 581–593. 91 indexed citations
11.
Esposito, Gennaro, Megan Garvey, Vera Alverdi, et al.. (2013). Monitoring the Interaction between β2-Microglobulin and the Molecular Chaperone αB-crystallin by NMR and Mass Spectrometry. Journal of Biological Chemistry. 288(24). 17844–17858. 30 indexed citations
12.
Garvey, Megan, Sarah Meehan, Sally L. Gras, et al.. (2013). A radish seed antifungal peptide with a high amyloid fibril-forming propensity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1834(8). 1615–1623. 30 indexed citations
13.
Garvey, Megan & Isabel Morgado. (2013). Peptide concentration alters intermediate species in amyloid β fibrillation kinetics. Biochemical and Biophysical Research Communications. 433(3). 276–280. 5 indexed citations
14.
Garvey, Megan, Stefani S. Griesser, Hans J. Griesser, et al.. (2011). Enhanced molecular chaperone activity of the small heat‐shock protein αB‐crystallin following covalent immobilization onto a solid‐phase support. Biopolymers. 95(6). 376–389. 12 indexed citations
15.
Garvey, Megan, Katharina Tepper, Caroline Haupt, et al.. (2011). Phosphate and HEPES buffers potently affect the fibrillation and oligomerization mechanism of Alzheimer’s Aβ peptide. Biochemical and Biophysical Research Communications. 409(3). 385–388. 29 indexed citations
16.
Garvey, Megan, Michael Kovermann, Alexander Vogel, et al.. (2010). DHPC Strongly Affects the Structure and Oligomerization Propensity of Alzheimer's Aβ(1–40) Peptide. Journal of Molecular Biology. 403(4). 643–659. 28 indexed citations
17.
Garvey, Megan, Sally L. Gras, Sarah Meehan, et al.. (2009). Protein nanofibres of defined morphology prepared from mixtures of crude crystallins. International Journal of Nanotechnology. 6(3/4). 258–258. 21 indexed citations
18.
Duttaroy, Asim K., et al.. (1990). Effects of linoleic and gamma-linolenic acids (efamol evening primrose oil) on fatty acid-binding proteins of rat liver. Molecular and Cellular Biochemistry. 98(1-2). 177–82. 7 indexed citations
19.
Garvey, Megan, et al.. (1981). Acid excretion by bicarbonate-free perfused rat kidney. American Journal of Physiology-Renal Physiology. 240(4). F306–F310. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.C.C. Tonoli Breakdown of academic impact, for papers by Dina R. Ivanen Breakdown of academic impact, for papers by Yunfeng Ding Breakdown of academic impact, for papers by Orly Tabachnikov Breakdown of academic impact, for papers by Hiroko Tsutsumi Breakdown of academic impact, for papers by Sofie Stalmans Breakdown of academic impact, for papers by Bert Gevaert Breakdown of academic impact, for papers by Markus Matuschek Breakdown of academic impact, for papers by R.K. Wierenga Breakdown of academic impact, for papers by Franck Fudalej
Rankless by CCL
2026